PRIMARY STUDY
β-Caryophyllene attenuates lipopolysaccharide-induced acute lung injury via inhibition of the MAPK signalling pathway
Key Findings: Resulting data revealed that BCP protects against inflammatory responses. The authors posit that BCP is a potentially novel therapeutic compound for the treatment of lipopolysaccharide-induced acute lung injury.
Type of Study: Animal Study
Study Result: Positive
Study Location(s): China
Year of Pub: 2021
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
Ligands Studied: Anti-inflammatory cytokines, Pro-inflammatory cytokines
